FDA Confirms It’s Moving Forward with New Phase of Mifepristone Safety Review

‘Every woman deserves the highest standard of medical care,’ said Carol Tobias, president of National Right to Life. ‘We encourage the agency to conduct this review with transparency, scientific integrity, and an unwavering commitment to protecting women.’

FDA Will Conduct Investigation into Abortion Pill Following Blockbuster Study on Risks

The move follows the recent release of a new study finding that the serious adverse reaction rate associated with mifepristone is far higher than previously reported.

Tagged Food and Drug AdministrationJosh HawleyRobert F. Kennedy Jr.